These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 7823133)
1. Expression and antibody inhibition of P-type calcium channels in human small-cell lung carcinoma cells. Barry EL; Viglione MP; Kim YI; Froehner SC J Neurosci; 1995 Jan; 15(1 Pt 1):274-83. PubMed ID: 7823133 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of calcium currents and exocytosis by Lambert-Eaton syndrome antibodies in human lung cancer cells. Viglione MP; O'Shaughnessy TJ; Kim YI J Physiol; 1995 Oct; 488 ( Pt 2)(Pt 2):303-17. PubMed ID: 8568672 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of voltage-gated Ca2+ channel activity in small cell lung carcinoma by the Ca2+/calmodulin-dependent protein kinase inhibitor KN-62 (1-[N,O-bis(5-isoquinolinesulfonyl)-N-methyl-L-tyrosyl]-4-phenylpiperaz ine) . Williams CL; Porter RA; Phelps SH Biochem Pharmacol; 1995 Dec; 50(12):1979-85. PubMed ID: 8849323 [TBL] [Abstract][Full Text] [Related]
4. Molecular diversity of neuronal-type calcium channels identified in small cell lung carcinoma. Oguro-Okano M; Griesmann GE; Wieben ED; Slaymaker SJ; Snutch TP; Lennon VA Mayo Clin Proc; 1992 Dec; 67(12):1150-9. PubMed ID: 1335101 [TBL] [Abstract][Full Text] [Related]
5. Antibodies to synthetic peptides of the alpha1A subunit of the voltage-gated calcium channel in Lambert-Eaton myasthenic syndrome. Takamori M; Iwasa K; Komai K Neurology; 1997 May; 48(5):1261-5. PubMed ID: 9153453 [TBL] [Abstract][Full Text] [Related]
6. Characterization of Ca2+ channel currents in cultured rat cerebellar granule neurones. Pearson HA; Sutton KG; Scott RH; Dolphin AC J Physiol; 1995 Feb; 482 ( Pt 3)(Pt 3):493-509. PubMed ID: 7738844 [TBL] [Abstract][Full Text] [Related]
7. Lambert-Eaton myasthenic syndrome immunoglobulins react with multiple types of calcium channels in small-cell lung carcinoma. Meriney SD; Hulsizer SC; Lennon VA; Grinnell AD Ann Neurol; 1996 Nov; 40(5):739-49. PubMed ID: 8957015 [TBL] [Abstract][Full Text] [Related]
8. Calcium-channel antibodies in the Lambert-Eaton syndrome and other paraneoplastic syndromes. Lennon VA; Kryzer TJ; Griesmann GE; O'Suilleabhain PE; Windebank AJ; Woppmann A; Miljanich GP; Lambert EH N Engl J Med; 1995 Jun; 332(22):1467-74. PubMed ID: 7739683 [TBL] [Abstract][Full Text] [Related]
9. Heterogeneity of calcium channel autoantibodies detected using a small-cell lung cancer line derived from a Lambert-Eaton myasthenic syndrome patient. Johnston I; Lang B; Leys K; Newsom-Davis J Neurology; 1994 Feb; 44(2):334-8. PubMed ID: 8309586 [TBL] [Abstract][Full Text] [Related]
10. Voltage-operated calcium channels in small cell lung carcinoma cell lines: pharmacological, functional, and immunological properties. Sher E; Pandiella A; Clementi F Cancer Res; 1990 Jul; 50(13):3892-6. PubMed ID: 2162247 [TBL] [Abstract][Full Text] [Related]
11. Neutral endopeptidase: variable expression in human lung, inactivation in lung cancer, and modulation of peptide-induced calcium flux. Cohen AJ; Bunn PA; Franklin W; Magill-Solc C; Hartmann C; Helfrich B; Gilman L; Folkvord J; Helm K; Miller YE Cancer Res; 1996 Feb; 56(4):831-9. PubMed ID: 8631021 [TBL] [Abstract][Full Text] [Related]
12. P/Q-type voltage-gated calcium channel antibodies in paraneoplastic disorders of the central nervous system. Voltz R; Carpentier AF; Rosenfeld MR; Posner JB; Dalmau J Muscle Nerve; 1999 Jan; 22(1):119-22. PubMed ID: 9883867 [TBL] [Abstract][Full Text] [Related]
13. Effects of neuropeptide analogues on calcium flux and proliferation in lung cancer cell lines. Bunn PA; Chan D; Stewart J; Gera L; Tolley R; Jewett P; Tagawa M; Alford C; Mochzuki T; Yanaihara N Cancer Res; 1994 Jul; 54(13):3602-10. PubMed ID: 7516822 [TBL] [Abstract][Full Text] [Related]
14. Expression of Ca2+/calmodulin-dependent protein kinase types II and IV, and reduced DNA synthesis due to the Ca2+/calmodulin-dependent protein kinase inhibitor KN-62 (1-[N,O-bis(5-isoquinolinesulfonyl)-N-methyl-L-tyrosyl]-4-phenyl piperazine) in small cell lung carcinoma. Williams CL; Phelps SH; Porter RA Biochem Pharmacol; 1996 Mar; 51(5):707-15. PubMed ID: 8615909 [TBL] [Abstract][Full Text] [Related]
15. Voltage-dependent sodium channels in human small-cell lung cancer cells: role in action potentials and inhibition by Lambert-Eaton syndrome IgG. Blandino JK; Viglione MP; Bradley WA; Oie HK; Kim YI J Membr Biol; 1995 Jan; 143(2):153-63. PubMed ID: 7731034 [TBL] [Abstract][Full Text] [Related]
17. Molecular and pharmacological properties of inwardly rectifying K+ channels of human lung cancer cells. Sakai H; Shimizu T; Hori K; Ikari A; Asano S; Takeguchi N Eur J Pharmacol; 2002 Jan; 435(2-3):125-33. PubMed ID: 11821018 [TBL] [Abstract][Full Text] [Related]
18. Activation of voltage-operated Ca2+-channels in human small cell lung carcinoma by the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Sheppard BJ; Williams M; Plummer HK; Schuller HM Int J Oncol; 2000 Mar; 16(3):513-8. PubMed ID: 10675483 [TBL] [Abstract][Full Text] [Related]
19. CCKA and CCKB receptors are expressed in small cell lung cancer lines and mediate Ca2+ mobilization and clonal growth. Sethi T; Herget T; Wu SV; Walsh JH; Rozengurt E Cancer Res; 1993 Nov; 53(21):5208-13. PubMed ID: 8221657 [TBL] [Abstract][Full Text] [Related]
20. Calcium channel autoantibodies in myasthenic syndrome and small cell lung cancer. Pelucchi A; Ciceri E; Clementi F; Marazzini L; Foresi A; Sher E Am Rev Respir Dis; 1993 May; 147(5):1229-32. PubMed ID: 8387255 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]